Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8100
-0.0030 (-0.37%)
Mar 31, 2025, 2:04 PM EDT - Market open

Biofrontera Statistics

Total Valuation

Biofrontera has a market cap or net worth of $7.19 million. The enterprise value is $6.22 million.

Market Cap 7.19M
Enterprise Value 6.22M

Important Dates

The last earnings date was Friday, March 21, 2025, before market open.

Earnings Date Mar 21, 2025
Ex-Dividend Date n/a

Share Statistics

Biofrontera has 8.87 million shares outstanding. The number of shares has increased by 256.75% in one year.

Current Share Class 8.87M
Shares Outstanding 8.87M
Shares Change (YoY) +256.75%
Shares Change (QoQ) +31.04%
Owned by Insiders (%) 13.60%
Owned by Institutions (%) 22.98%
Float 6.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.12
Forward PS 0.15
PB Ratio 1.63
P/TBV Ratio 1.64
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.17
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.11.

Current Ratio 1.72
Quick Ratio 0.93
Debt / Equity 1.11
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -8.17

Financial Efficiency

Return on equity (ROE) is -384.98% and return on invested capital (ROIC) is -110.06%.

Return on Equity (ROE) -384.98%
Return on Assets (ROA) -43.00%
Return on Invested Capital (ROIC) -110.06%
Return on Capital Employed (ROCE) -170.73%
Revenue Per Employee $439,071
Profits Per Employee -$208,929
Employee Count 93
Asset Turnover 1.49
Inventory Turnover 2.12

Taxes

In the past 12 months, Biofrontera has paid $22,000 in taxes.

Income Tax 22,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -29.30% in the last 52 weeks. The beta is 0.31, so Biofrontera's price volatility has been lower than the market average.

Beta (5Y) 0.31
52-Week Price Change -29.30%
50-Day Moving Average 1.02
200-Day Moving Average 1.04
Relative Strength Index (RSI) 35.82
Average Volume (20 Days) 94,923

Short Selling Information

The latest short interest is 97,753, so 1.10% of the outstanding shares have been sold short.

Short Interest 97,753
Short Previous Month 81,720
Short % of Shares Out 1.10%
Short % of Float 1.57%
Short Ratio (days to cover) 1.34

Income Statement

In the last 12 months, Biofrontera had revenue of $37.32 million and -$17.76 million in losses. Loss per share was -$3.22.

Revenue 37.32M
Gross Profit 18.71M
Operating Income -17.21M
Pretax Income -23.08M
Net Income -17.76M
EBITDA -16.79M
EBIT -17.21M
Loss Per Share -$3.22
Full Income Statement

Balance Sheet

The company has $5.91 million in cash and $4.92 million in debt, giving a net cash position of $990,000 or $0.11 per share.

Cash & Cash Equivalents 5.91M
Total Debt 4.92M
Net Cash 990,000
Net Cash Per Share $0.11
Equity (Book Value) 4.43M
Book Value Per Share 0.50
Working Capital 8.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.27 million and capital expenditures -$10,000, giving a free cash flow of -$10.28 million.

Operating Cash Flow -10.27M
Capital Expenditures -10,000
Free Cash Flow -10.28M
FCF Per Share -$1.16
Full Cash Flow Statement

Margins

Gross margin is 50.14%, with operating and profit margins of -46.11% and -47.58%.

Gross Margin 50.14%
Operating Margin -46.11%
Pretax Margin -47.53%
Profit Margin -47.58%
EBITDA Margin -44.99%
EBIT Margin -46.11%
FCF Margin n/a

Dividends & Yields

Biofrontera does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -256.75%
Shareholder Yield -256.75%
Earnings Yield -246.16%
FCF Yield -142.49%

Analyst Forecast

The average price target for Biofrontera is $7.00, which is 764.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 764.20%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 25.32%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 5, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date Jul 5, 2023
Split Type Reverse
Split Ratio 0.05:1

Scores

Biofrontera has an Altman Z-Score of -7.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.65
Piotroski F-Score 4